Similarly, CD86 expression demonstrated to be prognostic on DSS in four cancer types: LGG (HR = 2.3, 95%CI [1.3, 4.1], log-rank P < 0.001) (Figure 3F), SKCM (HR = 2.3, 95%CI [1.3, 4.1], log-rank P < 0.001) (Figure 3G), UVM (HR = 2.3, 95%CI [1.3, 4.1], log-rank P < 0.001) (Figure 3H), and CESC (HR = 2.3, 95%CI [1.3, 4.1], log-rank P = 0.013) (Figure 3I). The gene discussed is CD86; the disease is cancer.